Publications

Journal Article
Research Support, Non-U.S. Gov't
Epublish 118 citations
Electronic publication date
January 16, 2015

View on Pubmed.gov 24779365 | View on doi.org 10.1186/1756-05...

Cytotoxicity and activation of the Wnt/beta-catenin pathway in mouse embryonic stem cells treated with four GSK3 inhibitors.

Search for publications in this journal BMC Res Notes

Abstract

BACKGROUND

Small membrane-permeable molecules are now widely used during maintenance and differentiation of embryonic stem cells of different species. In particular the glycogen synthase kinase 3 (GSK3) is an interesting target, since its chemical inhibition activates the Wnt/beta-catenin pathway. In the present comparative study four GSK3 inhibitors were characterized.

METHODS

Cytotoxicity and potential to activate the Wnt/beta-catenin pathway were tested using the commonly used GSK3 inhibitors BIO, SB-216763, CHIR-99021, and CHIR-98014. Wnt/beta-catenin-dependent target genes were measured by quantitative PCR to confirm the Wnt-reporter assay and finally EC50-values were calculated.

RESULTS

CHIR-99021 and SB-216763 had the lowest toxicities in mouse embryonic stem cells and CHIR-98014 and BIO the highest toxicities. Only CHIR-99021 and CHIR-98014 lead to a strong induction of the Wnt/beta-catenin pathway, whereas BIO and SB-216763 showed a minor or no increase in activation of the Wnt/beta-catenin pathway over the natural ligand Wnt3a. The data from the Wnt-reporter assay were confirmed by gene expression analysis of the TCF/LEF regulated gene T.

CONCLUSIONS

Out of the four tested GSK3 inhibitors, only CHIR-99021 and CHIR-98014 proved to be potent pharmacological activators of the Wnt/beta-catenin signaling pathway. But only in the case of CHIR-99021 high potency was combined with very low toxicity.

References

Mech Dev. 2000 Mar 1;91(1-2):249-58

Nat Med. 2009 Jul;15(7):814-8

Curr Biol. 2003 Apr 15;13(8):680-5

Nat Med. 2004 Jan;10(1):55-63

Cited by 118 citations (total)

Journal Article

Structural insights into the polypharmacological activity of quercetin on serine/threonine kinases.

Electronic publication date May 10, 2017

Search for publications in this journal Drug Des Devel Ther

Bincy Baby [...] Ranjit Vijayan et al.

Polypharmacology, the discovery or design of drug molecules that can simultaneously interact with multiple targets, is gaining interest in contemporary...

Journal Article Research Support, Non-U.S. Gov't

Wnt/β-catenin-mediated signaling re-activates proliferation of matured cardiomyocytes.

Electronic publication date April 16, 2019

Search for publications in this journal Stem Cell Res Ther

Yong Fan [...] Boon-Seng Soh et al.

BACKGROUND

The Wnt/β-catenin signaling pathway plays an important role in the development of second heart field (SHF Isl1+) that gives rise...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances